Guangdong Association Of Clinical Trials
Clinical trials sponsored by Guangdong Association Of Clinical Trials, explained in plain language.
-
Blood test decides lung cancer treatment in new trial
Disease control Recruiting nowThis study is for people with stage II-IIIB non-small cell lung cancer who have had surgery after initial treatment with immunotherapy and chemotherapy. It tests whether using a sensitive blood test (called MRD) to detect tiny amounts of leftover cancer can help decide who needs …
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New drug duo targets 'Undruggable' lung cancer mutation in First-Line trial
Disease control Recruiting nowThis study is testing whether a new combination of two drugs (IBI351 and cetuximab β) can help control advanced lung cancer in people who have not yet received treatment and have a specific genetic change called KRAS G12C. The trial will enroll 48 adults to see how well the tumor…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Blood test guides next move in lung cancer fight
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer who have a specific genetic change (EGFR mutation). It tests if adding a second drug (sacituzumab tirumotecan) to their current medication (osimertinib) helps control the cancer better. The decision to add the seco…
Phase: PHASE2 • Sponsor: Guangdong Association of Clinical Trials • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC